Scott Hutton - Mar 1, 2023 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
President & CEO, Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Stock symbol
BDSX
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 03:16 PM
Previous filing
Feb 10, 2023
Next filing
May 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Stock Options (Right to buy) Award $0 +436K $0.00 436K Mar 1, 2023 Common Stock 436K $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option.